For the Inventor, By the Inventor

Enter assignee name

Fort Worth, TX, United States of America

Virbac Corporation

USPTO Granted Patents = 47

CIPO Patents = 2

EPO Patents = 28

Trademarks = 75

Forward Citations = 198

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Guy Derrieu (8 out of 22 patents)

Michel Robin (7 out of 7 patents)

Thomas A Miller (4 out of 4 patents)

4. Laurent Rodrigues (3 out of 3 patents)

5. Arnaud Steiner (3 out of 3 patents)

6. Patricia Monginoux (3 out of 3 patents)

7. Fanny Martins (3 out of 3 patents)

8. Nathalie Delhom (3 out of 3 patents)

9. Bertrand Havrileck (3 out of 4 patents)

10. Albert Ahn (3 out of 14 patents)

11. Ian Cottrell (3 out of 16 patents)

12. Benoît Berny (2 out of 2 patents)

13. Jean-Michel Brunel (2 out of 8 patents)

14. Jean-Pascal Marc (2 out of 2 patents)

15. Nicolas Brunel (2 out of 2 patents)

Core Competencies:

Glucocorticoids

Epithelial Infections

Veterinary Compositions

Squalamine Derivatives

Topical Compositions

Sustained Release Vaccines

Anthelmintic Formulations

Behavioral Disorders

Portable Fluid Dispenser

External Parasite Control

Nutritional Oral Compositions

Impact-Protection Devices

47 patents: Sort by Forward Citations

1. 12509425 - Tablet comprising modoflaner as an active component (2025-12-30),

2. 12478629 - Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals (2025-11-25),

3. 11819506 - Use of glucocorticoids for the treatment of epithelial microbial infections of a fluid containing organ with a natural exterior orifice in mammals (2023-11-21),

4. 11752127 - Methods and compositions for treatment of anxiety in animals (2023-09-12),

5. 11628973 - Impact-protection device capable of being provided on a bottle (2023-04-18),

6. 11364175 - Device for collecting a sample of a liquid contained in a container, associated container, and use of this container (2022-06-21),

7. 11325748 - Impact-protection device capable of being provided on a bottle (2022-05-10),

8. 11266789 - Multi-dose dispenser (2022-03-08),

9. 10780101 - Amide derivatives of squalamine for the treatment of infections (2020-09-22),

10. 10729701 - Compounds that are analogs of squalamine, used as antibacterial agents (2020-08-04),

11. D878214 - Bottle protector (2020-03-17),

12. 10548867 - Soothing composition for animals, comprising at least one fatty acid and nepetalactone (2020-02-04),

13. 10493032 - Nutritional and medicinal oral composition for veterinary use (2019-12-03),

14. 10426840 - Oil suspension of metronidazole (2019-10-01),

15. 10300012 - Topical composition comprising extracts of boldo and of meadowsweet, intended for an animal, and uses thereof (2019-05-28),

Virbac Corporation is a global animal health company that offers a wide range of pharmaceutical and biotechnological veterinary products. With a focus on research and development, Virbac strives to provide innovative solutions to animal health challenges. Their products span various categories such as vaccines, medications, dermatology, and dental care, catering to the needs of both companion and production animals. Committed to ethical practices and sustainability, Virbac operates in over 100 countries, contributing to the well-being of animals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

47 Patents

#25 in Fort Worth, TX

#404 in Texas

#7,203 in US

#14,440 in the World

Fort Worth, TX, United States of America

Virbac Corporation

Forward Citations = 198

67 inventors:

Guy Derrieu (8 out of 22 patents)

Michel Robin (7 out of 7 patents)

Thomas A Miller (4 out of 4 patents)

4. Laurent Rodrigues (3 out of 3 patents)

5. Arnaud Steiner (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…